Odanacatib in the treatment of postmenopausal women with low bone mineral density: Five years of continued therapy in a phase 2 study by Langdahl, Bente, Binkley, Neil, Bone, Henry, Gilchrist, Nigel, Resch, Heinrich, Rodriguez Portales, Jose, Denker, Andrew, Lombardi, Antonio, Le Bailly De Tilleghem, Celine, DaSilva, Carolyn, Rosenberg, Elizabeth, Leung, Albert

Get full text

EE159 Cost Effectiveness of Pembrolizumab Combined with Chemotherapy Vs. Chemotherapy As First-Line Treatment for Metastatic TNBC That Expresses PD-L1 in the United States by Huang, M, Fasching, P, Haiderali, A, Pan, W, Gray, E, Zhou, J, Hu, PH, Le Bailly De Tilleghem, C, Cappoen, N, Chaudhuri, M, O'Shaughnessy, J

Get full text

Efficacy and safety of losartan in children with Alport syndrome-results from a subgroup analysis of a prospective, randomized, placebo- or amlodipine-controlled trial by Webb, Nicholas J.A., Lam, Chun, Shahinfar, Shahnaz, Strehlau, Juergen, Wells, Thomas G., Gleim, Gilbert W., Le Bailly De Tilleghem, Céline

Get full text

De l'agriculture et de l'économie rurale en France, en Belgique, en Hollande et en Suisse / par Henri Colman,... ; traduit de l'anglais, par le baron Hector Le Bailly de Tilleghem... by Colman, Henry (1785-1849). Auteur du texte

Request full text

De l'agriculture et de l'économie rurale en France, en Belgique, en Hollande et en Suisse / par Henri Colman,... ; traduit de l'anglais, par le baron Hector Le Bailly de Tilleghem... by Colman, Henry (1785-1849). Auteur du texte

Request full text

Treatment with the cathepsin K inhibitor odanacatib in postmenopausal women with low BMD: 5year results of a phase 2 trial by Resch, H., Binkley, N., Bone, H., Eisman, J.A., Gilchrist, N., Langdahl, B., Portales, J. Rodriguez, Denker, A., Lombardi, A., De Tilleghem, C. Le Bailly, DaSilva, C., Rosenberg, E., Leung, A.

Get full text

Treatment with the cathepsin K inhibitor odanacatib in postmenopausal women with low BMD: 5 year results of a phase 2 trial by Resch, H, Binkley, N, Bone, H, Eisman, J.A, Gilchrist, N, Langdahl, B, Portales, J. Rodriguez, Denker, A, Lombardi, A, De Tilleghem, C. Le Bailly, DaSilva, C, Rosenberg, E, Leung, A

Get full text

Safety and tolerability of odanacatib therapy in postmenopausal women with osteoporosis: results from the phase III long-term odanacatib fracture trial by Papapoulos, S, McClung, MR, Langdahl, B, Saag, KG, Adami, S, Bone, HG, de Villiers, T, Kiel, DP, Kung, A, Kumar, P, Lim, SK, Ling, X, Lippuner, K, Mautalen, C, Nakamura, T, Reginster, Jean-Yves, Reid, IR, Rodriguez-Portales, JA, Roux, C, Walliser, J, Watts, NB, Zanchetta, J, Zerbini, CA, Rybak-Feiglin, A, Cohn, D, DaSilva, CA, Le Bailly De Tilleghem, C, Santora, A, Scott, BB, Verbruggen, N, Leung, A, Lombardi, A, Gurner, D

Get full text

A Fast Exchange Algorithm for Designing Focused Libraries in Lead Optimization by Le Bailly de Tilleghem, Céline, Beck, Benoît, Boulanger, Bruno, Govaerts, Bernadette

Get full text

Treatment with the cathepsin K inhibitor odanacatib in postmenopausal women with low BMD: 5year results of a phase 2 trial by Langdahl⁎, B., Binkley, N., Bone, H., Gilchrist, N., Resch, H., Rodriguez Portales, J., Lombardi, A., Denker, A., Le Bailly De Tilleghem, C.L.B.D.T., DaSilva, C., Rosenberg, E., Leung, A.

Get full text

Treatment with the cathepsin K inhibitor odanacatib in postmenopausal women with low BMD: 5 year results of a phase 2 trial by Langdahl, B, Binkley, N, Bone, H, Gilchrist, N, Resch, H, Rodriguez Portales, J, Lombardi, A, Denker, A, Le Bailly De Tilleghem, C.L.B.D.T, DaSilva, C, Rosenberg, E, Leung, A

Get full text